L01EC
SpainB-raf serine-threonine kinase (braf) inhibitors
- L01EC01 Vemurafenib 1 medications
- L01EC02 Dabrafenib 3 medications
- L01EC03 Encorafenib 2 medications
medicationsWithCode L01EC
-
Braftovi 50 mg hard capsules
Form: capsules, hard
Active substance Dosage ENCORAFENIB 50 mg ATC code: L01E, L01EC, L01EC03
Manufacturer: Pierre Fabre Medicament
-
Braftovi 75 mg hard capsules
Form: capsules, hard
Active substance Dosage ENCORAFENIB Igual a 75 mg mg ATC code: L01E, L01EC, L01EC03
Manufacturer: Pierre Fabre Medicament
-
Finlee 10 mg dispersible tablets
Form: tablets, dispersible
Active substance Dosage DABRAFENIB MESILATE 11,85 mg ATC code: L01E, L01EC, L01EC02
Manufacturer: Novartis Europharm Limited
-
Tafinlar 50 mg hard capsules
Form: capsules, hard
Active substance Dosage DABRAFENIB MESILATE 59,25 mg ATC code: L01E, L01EC, L01EC02
Manufacturer: Novartis Europharm Limited
-
Tafinlar 75 mg hard capsules
Form: capsules, hard
Active substance Dosage DABRAFENIB MESILATE 88,88 mg ATC code: L01E, L01EC, L01EC02
Manufacturer: Novartis Europharm Limited
-
Zelboraf 240 mg film-coated tablets
Form: tablets, film-coated
Active substance Dosage VEMURAFENIB 240 mg ATC code: L01E, L01EC, L01EC01
Manufacturer: Roche Registration Gmbh